InVivo Therapeutics and its subsidiary InVivo Therapeutics Corporation filed petitions for relief under Chapter 11 in the US.
- Company intends to continue to operate as a “debtor-in-possession”
- Also filed motions seeking approval of continuing business practices and a potential sale of its assets
To view the source of this information, click
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2025 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.